Influence of the American ODAC statement on Austrian bevacizumab prescribing practice for metastatic breast cancer. Posted byadmin 28. July 2020 Preusser M, Fülöp G, Berghoff AS, Heinzl H, Steger GG, Greil R, Zielinski CC, Bartsch R. http://www.ncbi.nlm.nih.gov/pubmed/22744818